Oncology News and Research

RSS

Oncology, meaning bulk, mass, or tumor, and the suffix ''-logy'', meaning "study of") is a branch of medicine that deals with tumors (cancer). A medical professional who practices oncology is an ''oncologist''.

MD Anderson receives $150 million grant from Khalifa Foundation for cancer research

The Khalifa bin Zayed Al Nahyan Charity Foundation is granting $150 million to The University of Texas MD Anderson Cancer Center to support genetic-analysis based research, diagnosis and treatment of cancer.

20 Jan 2011

Study: HIV-positive head and neck cancer patients respond well to radiation therapy treatments

HIV-positive head and neck cancer patients respond well to radiation therapy treatments and experience similar toxicity rates as non-HIV-positive patients, despite prior reports to the contrary, according to a study in the January issue of the International Journal of Radiation Oncology•Biology•Physics, an official journal of the American Society for Radiation Oncology.

19 Jan 2011

Data on Ensituximab for treatment of pancreatic and colorectal cancers to be presented at ASCO 2011

Neogenix Oncology announced today that Dr. Luis Diaz of The Johns Hopkins University Hospital will present data from Ensituximab, the company's novel, therapeutic antibody to treat pancreatic and colorectal cancers. The presentation is scheduled at the American Society of Clinical Oncology (ASCO) 2011 Gastrointestinal Cancers Symposium to be held January 20-22, 2011 at the Moscone Center in San Francisco, CA, USA.

19 Jan 2011

Geron commences enrollment in imetelstat Phase 2 clinical trial in essential thrombocythemia

Geron Corporation today announced enrollment of the first patient in a Phase 2 clinical trial to evaluate the activity of the company's telomerase inhibitor drug, imetelstat (GRN163L), in patients with essential thrombocythemia (ET).

19 Jan 2011

Case Western Reserve, Athersys enter partnership for scientific study on spinal cord injury

Case Western Reserve University School of Medicine and Athersys, Inc. announced a joint scientific study on spinal cord injury will be published today in the January issue of The Journal of Neuroscience.

19 Jan 2011

CareCore National and D3 partner to accelerate implementation of cancer care pathways

To improve quality and contain rising costs in cancer care, CareCore National and D3, an affiliate of UPMC, have formed a new company to accelerate implementation of cancer care pathways.

19 Jan 2011

Europe's leading oncology organisations receive €12 million grant to streamline cross border research

Europe's leading oncology organisations are combining forces in the global fight against cancer. The project, EurocanPlatform, has received €12 million from the European Union to streamline cross border research. The project will find moreeffective ways to ensure the prevention, early discovery and treatment of different forms of cancer.

19 Jan 2011

New long-term survival data from OPUS, CRYSTAL studies demonstrate strong tumor shrinkage of Erbitux

Merck Serono, a division of Merck KGaA, Darmstadt, Germany, today highlighted a further analysis of the large randomized Phase II OPUS study demonstrating an association between early tumor shrinkage and long-term median overall survival (OS) of more than 2 years for patients with KRAS wild-type metastatic colorectal cancer (mCRC) treated with Erbitux® (cetuximab) plus FOLFOX standard chemotherapy.

19 Jan 2011

Positive results from PLX4032 Phase 3 Trial in patients with metastatic melanoma

Plexxikon today announced positive data from an interim analysis of the BRIM3 trial, a large multi-center Phase 3 clinical study of PLX4032 in patients with previously untreated metastatic melanoma with the BRAF mutation. Patients treated with PLX4032 had an improved overall survival compared to patients treated with dacarbazine, the current standard of care.

19 Jan 2011

Diabetes increases risk of death in breast cancer patients

Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.

18 Jan 2011

PAM50 test is now available to classify breast cancer subtypes

ARUP Laboratories, a leading national clinical and anatomic pathology reference laboratory and a leader in innovative laboratory research and development, today announced the availability of a new laboratory developed test designed to classify breast cancer into clinically significant molecular subtypes that are important for the management of the disease.

18 Jan 2011

BSD Medical sells MicroThermX Microwave System to Med-Italia Biomedica

BSD Medical Corporation, a leading provider of medical systems that utilize heat therapy to treat cancer, today announced the sale and shipment of the MicroThermX Microwave System to Med-Italia Biomedica (Med-Italia), one of the largest interventional radiology/oncology distributors in Italy.

18 Jan 2011

GE Healthcare becomes US distributor and reseller of Veran's ig4 navigation system

GE Healthcare and Veran, a provider of proprietary 4D registration capability for precise targeting of lesions via its FDA cleared platform, today announced a strategic supplier agreement in which GE Healthcare becomes the exclusive distributor and reseller of Veran's ig4 navigation system in the United States.

18 Jan 2011

Clinipace Worldwide achieves over 800% revenue growth since 2008

Clinipace Worldwide, a global digital clinical research organization (dCRO), announced today that it recently closed its best year to date, achieving over 800% revenue growth since 2008. The company more than doubled its revenues in 2010 over the prior year, attributable to 16 new projects awarded from 12 new clients.

18 Jan 2011

Quebec reimburses VIDAZA for treatment of blood cancer

Quebec patients with serious blood cancers (intermediate-2 and high-risk myelodysplastic syndrome and acute myeloid leukemia) now have publicly funded access to a new innovative therapy, VIDAZA® (azacitidine). Following a priority review and subsequent positive recommendation from the Conseil du medicament, patients now have the potential to significantly extend survival.

18 Jan 2011

Women's Health Congress to explore mammography controversy

The ongoing controversy about the appropriate age, frequency, and patient benefit of mammography will be explored at the upcoming 19th Annual Congress on Women's Health, April 1-3, 2011 in Washington DC.

18 Jan 2011

Bathing tumor-ridden livers in chemotherapy increases survival time

Bathing tumor-ridden livers in chemotherapy increases the length of time certain cancer patients survive without progression of the disease, according to Phase III trial results being presented at the 3rd annual Symposium on Clinical Interventional Oncology (CIO), in collaboration with the International Symposium on Endovascular Therapy (ISET).

18 Jan 2011

PecFent accepted in Scotland for treatment of breakthrough cancer pain

Archimedes Pharma Ltd., a leading international specialty pharma company, today announced the decision by the Scottish Medicines Consortium to accept PecFent for use within NHS Scotland. PecFent is indicated for the treatment of breakthrough pain in adults who are already receiving maintenance opioid therapy for chronic cancer pain.

18 Jan 2011

Scientists identify new way of attacking breast cancer stem cells

Scientists at the University of Michigan Comprehensive Cancer Center have identified a potential new way of attacking breast cancer stem cells, the small number of cells in a tumor that fuel its growth and spread.

18 Jan 2011

Milk may reduce risk of bowel cancer: Study

Research by Associate Professor Brian Cox and Dr Mary Jane Sneyd of the Otago University’s Hugh Adam cancer epidemiology unit has shown that New Zealand schoolchildren who drank milk daily significantly reduced their chances of getting bowel cancer as adults.

17 Jan 2011

Oncology News and Research

Further Reading

MD Anderson receives $150 million grant from Khalifa Foundation for cancer research

Study: HIV-positive head and neck cancer patients respond well to radiation therapy treatments

Data on Ensituximab for treatment of pancreatic and colorectal cancers to be presented at ASCO 2011

Geron commences enrollment in imetelstat Phase 2 clinical trial in essential thrombocythemia

Case Western Reserve, Athersys enter partnership for scientific study on spinal cord injury

CareCore National and D3 partner to accelerate implementation of cancer care pathways

Europe's leading oncology organisations receive €12 million grant to streamline cross border research

New long-term survival data from OPUS, CRYSTAL studies demonstrate strong tumor shrinkage of Erbitux

Positive results from PLX4032 Phase 3 Trial in patients with metastatic melanoma

Diabetes increases risk of death in breast cancer patients

PAM50 test is now available to classify breast cancer subtypes

BSD Medical sells MicroThermX Microwave System to Med-Italia Biomedica

GE Healthcare becomes US distributor and reseller of Veran's ig4 navigation system

Clinipace Worldwide achieves over 800% revenue growth since 2008

Quebec reimburses VIDAZA for treatment of blood cancer

Women's Health Congress to explore mammography controversy

Bathing tumor-ridden livers in chemotherapy increases survival time

PecFent accepted in Scotland for treatment of breakthrough cancer pain

Scientists identify new way of attacking breast cancer stem cells

Milk may reduce risk of bowel cancer: Study

Cancer Research - Second Edition eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News